Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Pure Semaglutide

R 540.00 R 500.00

Pure Semaglutide 30mg: Pure Semaglutide 10mg

Add to WishlistCompare

Semaglutide — Research-Grade Peptide

Semaglutide 30mg is a research-grade peptide supplied by Pure Performance Labs as lyophilised material for controlled laboratory and scientific research. Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1) and is extensively studied in metabolic and receptor research.

The 30mg presentation provides a defined quantity of research material for laboratory investigations requiring a consistent sample.

This product is supplied strictly for laboratory and scientific research purposes and is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

Research Overview

Semaglutide is a modified GLP-1 analogue investigated in scientific research involving GLP-1 receptor activity, metabolic signalling and related biological pathways.

Research into semaglutide includes investigation of receptor interactions, cellular signalling and molecular characteristics relevant to metabolic and biochemical research.

Product Information

• Product: Semaglutide
• Strength: 30mg - 10mg
• Format: Lyophilised research material
• CAS: 910463-68-2
• Supplier: Pure Performance Labs
• Research category: Metabolic Research
• Intended use: Laboratory research only

Research Areas

Semaglutide may be of interest to researchers investigating:

• GLP-1 receptor signalling
• Metabolic research
• Peptide-receptor interactions
• Cellular signalling
• Biochemical research
• Receptor pharmacology
• Molecular biology

Research-Use Notice

This product is supplied strictly for laboratory and scientific research purposes. It is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

The official Pure Labs page confirms the 30mg reference strength, CAS number, research classification and its positioning within Metabolic Research.

Key Features

• Semaglutide 30mg research-grade peptide
• Lyophilised research material
• Defined 30mg presentation
• GLP-1 analogue investigated in metabolic research
• Research interest includes GLP-1 receptor signalling
• Suitable for controlled laboratory research
• Supplied by Pure Performance Labs
• Research use only

Dosage & Usage

Semaglutide is a synthetic GLP-1 analogue extensively investigated in scientific literature relating to GLP-1 receptor activity, metabolic signalling, peptide pharmacology and related biochemical research. This field provides general research context only and should not be interpreted as evidence of clinical efficacy for this product. Batch-specific analytical information should be verified against the applicable Certificate of Analysis.

FAQ's & Tips

What is Semaglutide 30mg?
Semaglutide 30mg is a research-grade GLP-1 analogue supplied as lyophilised material for controlled laboratory and scientific research.

What is semaglutide studied for?
Semaglutide is investigated in research involving GLP-1 receptor signalling, metabolic biology, peptide-receptor interactions and related biochemical pathways.

What format is Semaglutide 30mg supplied in?
The product is supplied as lyophilised research material in a defined 30mg presentation.

What is the research category for Semaglutide 30mg?
Semaglutide 30mg is classified under Metabolic Research.

Is Semaglutide 30mg for human use?
No. This product is supplied strictly for laboratory and scientific research purposes and is not intended for human or veterinary use.

Where can I find batch-specific analytical information?
Refer to the applicable Certificate of Analysis and batch documentation when available.

Is this product a pre-filled pen?
No. This listing is for the 30mg research presentation. Pre-filled research pen products are listed separately.

Research

Semaglutide is a long-acting GLP-1 receptor agonist. Research has characterised its effects on GLP-1 receptor signalling, glucose-dependent insulin secretion, glucagon regulation, gastric emptying and appetite-related pathways. Extensive clinical literature exists for approved pharmaceutical formulations, but this research product is not presented as a medical treatment. For laboratory research use only.

Reviews